• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗对充血性心力衰竭中功能性二尖瓣反流潜在机制的影响。

Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.

作者信息

Porciani Maria Cristina, Macioce Roberto, Demarchi Gabriele, Chiostri Marco, Musilli Nicola, Cappelli Francesco, Lilli Alessio, Ricciardi Giuseppe, Padeletti Luigi

机构信息

University of Florence, Institute of Internal Medicine and Cardiology, V. le Morgagni 85, 50134 Florence, Italy.

出版信息

Eur J Echocardiogr. 2006 Jan;7(1):31-9. doi: 10.1016/j.euje.2005.03.008.

DOI:10.1016/j.euje.2005.03.008
PMID:16378918
Abstract

AIMS

Functional mitral regurgitation (FMR) improvement induced by cardiac resynchronization therapy (CRT) has been related to left ventricular (LV) remodeling reversal and contractility enhancement. The effects induced by the changes of LV synchronicity indexes on FMR severity have not been investigated.

METHODS AND RESULTS

In 30 patients with CRT for heart failure (HF) and QRS>130 ms, LV function parameters, FMR severity as mitral jet regurgitation/left atrial area ratio (JA/LAA) and standard deviation (SD) of the time to the systolic peak velocity at 6-basal and mid-LV segments as asynchrony indexes were evaluated (echo/tissue Doppler) before and 6 months after implant. At follow-up, 15 patients resulted responders to LV reverse remodeling with > or =15% end-systolic volume (ESV) and LV systolic function improvement. Improvement of FMR with > or =15% JA/LAA reduction was observed in 19 patients, 7 were nonresponders to LV reverse remodeling. In patients with > or =15% JA/LAA reduction a significant decrease of LV asynchrony indexes was observed as compared to patients without > or =15% JA/LAA reduction in whom LV asynchrony indexes were increased. Reduction of LV mid-segmental asynchrony was the variable most strongly related to JA/LAA reduction (r(2)=0.697, P<0.01), with good agreement between observed and predicted values (only 1 patient outside the mean+/-2SD).

CONCLUSION

These data reveal that CRT can reduce FMR irrespective to LV remodeling reversal; this effect is related to LV asynchrony reduction and further support CRT employment in patients with HF and FMR.

摘要

目的

心脏再同步治疗(CRT)所诱导的功能性二尖瓣反流(FMR)改善与左心室(LV)重构逆转和收缩力增强有关。LV同步性指标变化对FMR严重程度的影响尚未得到研究。

方法与结果

在30例接受CRT治疗心力衰竭(HF)且QRS>130 ms的患者中,在植入前及植入后6个月评估LV功能参数、作为二尖瓣反流/左心房面积比(JA/LAA)的FMR严重程度以及6个LV基底段和中段至收缩期峰值速度时间的标准差(SD)作为不同步指标(超声心动图/组织多普勒)。随访时,15例患者出现LV逆向重构反应,左室收缩末期容积(ESV)减少≥15%且LV收缩功能改善。19例患者观察到FMR改善,JA/LAA降低≥15%,7例对LV逆向重构无反应。与JA/LAA降低未达到≥15%且LV不同步指标增加的患者相比,JA/LAA降低≥15%的患者LV不同步指标显著降低。LV中段不同步性降低是与JA/LAA降低最密切相关的变量(r² = 0.697,P<0.01),观察值与预测值之间具有良好的一致性(仅1例患者超出均值±2SD)。

结论

这些数据表明,CRT可降低FMR,而与LV重构逆转无关;这种效应与LV不同步性降低有关,并进一步支持在HF和FMR患者中应用CRT。

相似文献

1
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.心脏再同步治疗对充血性心力衰竭中功能性二尖瓣反流潜在机制的影响。
Eur J Echocardiogr. 2006 Jan;7(1):31-9. doi: 10.1016/j.euje.2005.03.008.
2
Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.心脏再同步治疗中功能性二尖瓣反流对逆向重构的影响
Europace. 2007 Sep;9(9):757-61. doi: 10.1093/europace/eum122. Epub 2007 Jun 15.
3
Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.重度充血性心力衰竭患者心脏再同步治疗后左心室逆向重构的预测参数
Ital Heart J. 2005 Sep;6(9):734-9.
4
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy.二尖瓣环节段再同步化可减少心脏再同步化治疗中的功能性二尖瓣反流。
Minerva Cardioangiol. 2005 Aug;53(4):329-33.
5
Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?左心室舒张功能和舒张不同步是心脏再同步治疗反应的重要决定因素吗?
Am J Cardiol. 2006 Oct 15;98(8):1083-7. doi: 10.1016/j.amjcard.2006.05.028. Epub 2006 Aug 30.
6
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.左心室不同步可预测心脏再同步治疗后的反应及预后。
J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40. doi: 10.1016/j.jacc.2004.08.016.
7
Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.心脏再同步治疗对功能性二尖瓣反流的长期影响。
Am J Cardiol. 2009 Aug 1;104(3):383-8. doi: 10.1016/j.amjcard.2009.03.060. Epub 2009 Jun 6.
8
Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.心脏再同步治疗对充血性心力衰竭患者疾病进展的影响。
Ital Heart J. 2004 May;5(5):364-70.
9
Reduction in mitral regurgitation in patients undergoing cardiac resynchronization treatment: assessment of predictors by two-dimensional radial strain echocardiography.心脏再同步治疗患者二尖瓣反流的减少:二维径向应变超声心动图对预测因素的评估
Echocardiography. 2009 Apr;26(4):420-30. doi: 10.1111/j.1540-8175.2008.00823.x.
10
A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.一种通过组织同步成像评估收缩期不同步并识别心脏再同步治疗反应者的新型工具。
J Am Coll Cardiol. 2005 Mar 1;45(5):677-84. doi: 10.1016/j.jacc.2004.12.003.

引用本文的文献

1
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.心脏植入式电子设备后三尖瓣和二尖瓣反流的演变和预后:系统评价和荟萃分析。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae143.
2
The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation.心脏再同步治疗在功能性二尖瓣反流管理中的作用。
Cells. 2022 Aug 4;11(15):2407. doi: 10.3390/cells11152407.
3
Predictors of persistence of functional mitral regurgitation after cardiac resynchronization therapy: Review of literature.
心脏再同步治疗后功能性二尖瓣反流持续存在的预测因素:文献综述
World J Cardiol. 2022 Mar 26;14(3):170-176. doi: 10.4330/wjc.v14.i3.170.
4
Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies.缺血性二尖瓣反流:一种治疗方法不断发展的多方面综合征。
Biomedicines. 2021 Apr 21;9(5):447. doi: 10.3390/biomedicines9050447.
5
Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes.心脏 CT 评估的左心室壁厚度与心脏再同步治疗结局。
Europace. 2020 Mar 1;22(3):401-411. doi: 10.1093/europace/euz322.
6
Effect of cardiac resynchronization therapy on mitral valve geometry: a novel aspect as "reversed mitral remodeling".心脏再同步治疗对二尖瓣几何形态的影响:作为“逆向二尖瓣重塑”的一个新方面。
Int J Cardiovasc Imaging. 2018 Jul;34(7):1029-1040. doi: 10.1007/s10554-018-1308-2. Epub 2018 Jan 31.
7
Implantation of CARILLON Mitral Contour System with transvenous left ventricular lead in place.CARILLON 二尖瓣成形系统在经皮左心室导线到位的情况下植入。
Clin Res Cardiol. 2017 Oct;106(10):796-801. doi: 10.1007/s00392-017-1121-2. Epub 2017 May 5.
8
Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block?心脏再同步治疗还是 MitraClip® 植入术用于重度二尖瓣反流合并左束支传导阻滞患者?
Arrhythm Electrophysiol Rev. 2014 Nov;3(3):190-3. doi: 10.15420/aer.2014.3.3.190. Epub 2014 Nov 29.
9
Tricuspid valve regurgitation following temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy.临时或永久性心内膜导线植入后三尖瓣反流及心脏再同步治疗的影响
Open Cardiovasc Med J. 2014 Dec 31;8:113-20. doi: 10.2174/1874192401408010113. eCollection 2014.
10
Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.心力衰竭中的缺血性和功能性二尖瓣反流:自然病史与治疗
Curr Cardiol Rep. 2014 Aug;16(8):517. doi: 10.1007/s11886-014-0517-0.